Microphysiological Systems standard NCATS Tissue Chip Program IQ Consortium MPS affiliate NASA Tissue chips in space EMA + FDA Regulatory qualification Multi-organ Body-on-chip Microphysiological Systems standard NCATS Tissue Chip Program IQ Consortium MPS affiliate NASA Tissue chips in space EMA + FDA Regulatory qualification Multi-organ Body-on-chip
Biological MPS Platforms

The BioMPS Standard

Biological microphysiological systems represent the gold standard in human-relevant testing. BioMPS platforms combine living cells, tissue engineering, and microfluidics to predict drug safety and efficacy with unprecedented accuracy.

LIVER HEART KIDNEY GUT LUNG BRAIN MULTI-ORGAN BioMPS
$1.5B
MPS Market 2030
12+
Organ Types
90%
Clinical Translation
35%
CAGR Growth

BioMPS Capabilities

Comprehensive human biology on a platform

🧬

Multi-Organ Systems

Connect multiple organ chips fluidically to model systemic drug distribution, metabolism, and off-target effects across the body.

🔬

Physiological Flow

Perfusion at physiological shear rates and pressures. Blood surrogate or real blood for immune-competent systems.

📈

PBPK Integration

Combine MPS data with computational PBPK models for in silico human predictions. Quantitative systems pharmacology.

🎯

Disease States

Model NASH, fibrosis, inflammation, infection, and cancer on-chip. Patient-derived cells for personalized disease avatars.

High-Content Readouts

Imaging, omics, electrophysiology, and biosensors. Multi-parametric data for mechanistic understanding.

💡

Regulatory Path

IND-enabling studies accepted by FDA. ISTAND program validation. Path to replacing animal studies in drug development.

Own the BioMPS Brand

BioMPS.com - Premium domain for microphysiological systems. Ideal for platforms, consortia, or commercial applications.

Contact for Pricing

Own Biomps

This premium domain is available for acquisition. Perfect for companies, startups, or investors in this space.

Submit your inquiry below and we'll respond within 24 hours.